LBA-09 Cetuximab beyond progression in RAS wild type (WT) metastatic colorectal cancer (mCRC): the CAPRI-GOIM randomized phase II study of FOLFOX versus FOLFOX plus cetuximab
2015 ◽
Vol 26
◽
pp. iv120
◽
F. Ciardiello
◽
N. Normanno
◽
E. Martinelli
◽
T. Troiani
◽
C. Cardone
◽
...
Naoki Nagata
◽
Hiromichi Maeda
◽
Keiichiro Ishibashi
◽
Keiji Hirata
◽
Akitaka Makiyama
◽
...
2010 ◽
Vol 28
(15_suppl)
◽
pp. TPS189-TPS189
L. S. Schwartzberg
◽
V. J. Wagner
2014 ◽
Vol 32
(15_suppl)
◽
pp. TPS3662-TPS3662
Kohei Shitara
◽
Kentaro Yamazaki
◽
Hiroyuki Uetake
◽
Takeshi Kato
◽
Eiji Oki
◽
...
2014 ◽
Vol 32
(15_suppl)
◽
pp. TPS3649-TPS3649
◽
Josep Tabernero
◽
Nicoletta Brega
◽
Craig Davis
◽
Ashwin Gollerkeri
◽
Kristen Pierce
◽
...
T. Tamura
◽
D. Sakai
◽
N. Sugimoto
◽
S. Tokunaga
◽
A. Tsuji
◽
...
Francesca Battaglin
◽
Marta Schirripa
◽
Federica Buggin
◽
Filippo Pietrantonio
◽
Federica Morano
◽
...
Andrew G. Hill
◽
Michael Findlay
◽
Matthew Burge
◽
Christopher Jackson
◽
Pilar Garcia Alfonso
◽
...
2016 ◽
Vol 34
(15_suppl)
◽
pp. TPS3627-TPS3627
Roberto Moretto
◽
Francesca Battaglin
◽
Carlotta Antoniotti
◽
Federica Buggin
◽
Laura Delliponti
◽
...
2018 ◽
Vol 29
◽
pp. viii204
T. Mazard
◽
F. Ghiringhelli
◽
C. Mollevi
◽
E. Assenat
◽
C. Gavoille
◽
...
Roberto Moretto
◽
Daniele Rossini
◽
Iolanda Capone
◽
Alessandra Boccaccino
◽
Federica Perrone
◽
...
Close
Export Citation Format
Close
Share Document
Close